Evidence suggests that blocking the ERK1/2 cascade can trigger the compensatory activation of alternative oncogenic pathways such as PI3K-AKT [138], which are themselves frequently dysregulated in iCCA [28]. The gene discussed is MAPK3; the disease is infantile convulsions and choreoathetosis.